Answers are grounded in this paper and cite their sources.
Functional pituitary reserve in 18 patients with the amenorrhea-galactorrhea syndrome was evaluated using luteinizing hormone-releasing hormone (LH-RH), l-dopa, and chlorpromazine. Gonadotropin release after administration of synthetic LH-RH varied widely from that seen in normal women to that below the normal range; however, cases with pituitary tumor exhibited the lowest responses or no responses to LH-RH. Prolactin release in response to drugs which normally either stimulate (chlorpromazine) or inhibit (l-dopa) its secretion, also varied widely regardless of the presence or not of a pituitary tumor. It is concluded that LH-RH is a reliable test to determine the pituitary reserve in cases of galactorrhea associated with amenorrhea. These results suggest that high prolactin levels associated with a deficient secretion of gonadotropin in response to LH-RH may be indicative of an underlying pituitary tumor, even in the absence of sellar enlargement.
No takes yet. Share an insight, caveat, or question.
Zárate et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: